Surgery Partners Stock Forecast, Price & News

Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

Is Surgery Partners a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Surgery Partners stock.
View analyst ratings for Surgery Partners or view top-rated stocks.

How has Surgery Partners' stock price been impacted by Coronavirus?

Surgery Partners' stock was trading at $8.86 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SGRY shares have increased by 375.1% and is now trading at $42.09.
View which stocks have been most impacted by COVID-19.

Are investors shorting Surgery Partners?

Surgery Partners saw a increase in short interest in December. As of December 31st, there was short interest totaling 1,760,000 shares, an increase of 17.3% from the December 15th total of 1,500,000 shares. Based on an average daily volume of 382,400 shares, the days-to-cover ratio is currently 4.6 days. Approximately 4.6% of the shares of the stock are sold short.
View Surgery Partners' Short Interest.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release its next quarterly earnings announcement on Wednesday, March 9th 2022.
View our earnings forecast for Surgery Partners.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) posted its quarterly earnings results on Tuesday, November, 2nd. The company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.04. The business had revenue of $559.20 million for the quarter, compared to the consensus estimate of $554.15 million. Surgery Partners had a negative net margin of 3.02% and a negative trailing twelve-month return on equity of 0.81%. During the same quarter in the prior year, the firm earned ($0.59) EPS.
View Surgery Partners' earnings history.

What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners issued an update on its FY 2021 earnings guidance on Tuesday, November, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.21 billion-$2.25 billion, compared to the consensus revenue estimate of $2.22 billion.

What price target have analysts set for SGRY?

6 equities research analysts have issued 1 year target prices for Surgery Partners' stock. Their forecasts range from $50.00 to $73.00. On average, they expect Surgery Partners' stock price to reach $57.67 in the next year. This suggests a possible upside of 37.0% from the stock's current price.
View analysts' price targets for Surgery Partners or view top-rated stocks among Wall Street analysts.

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the following people:

• J. Eric Evans, Chief Executive Officer & Director
• Thomas F. Cowhey, CFO, Principal Accounting Officer & Executive VP
• Varun Gadhok, Chief Information Officer & Senior Vice President
• Roxanne Womack, Chief Compliance Officer & Senior Vice President
• Jennifer B. Baldock, Secretary, Chief Administrative Officer & EVP (LinkedIn Profile)

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners CEO Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among Surgery Partners' employees.

Who are some of Surgery Partners' key competitors?

Some companies that are related to Surgery Partners include Universal Health Services (UHS), Tenet Healthcare (THC), Community Health Systems (CYH), SunLink Health Systems (SSY), Rennova Health (RNVA), Ethema Health (GRST), Rennova Health (RNVAD) and First Physicians Capital Group (FPCG).
View all of SGRY's competitors.

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO), Xilinx (XLNX), Allena Pharmaceuticals (ALNA), Editas Medicine (EDIT) and Maxar Technologies (MAXR).

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by many different retail and institutional investors. Top institutional investors include Foster Victor Wealth Advisors LLC (0.01%) and Cutler Group LP (0.00%). Company insiders that own Surgery Partners stock include Anthony Taparo, George Goodwin, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Teresa Deluca and Thomas F Cowhey.
View institutional ownership trends for Surgery Partners.

Which institutional investors are selling Surgery Partners stock?

SGRY stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP. Company insiders that have sold Surgery Partners company stock in the last year include Anthony Taparo, George Goodwin, Jennifer Baldock, Laura L Brocklehurst, Teresa Deluca, and Thomas F Cowhey.
View insider buying and selling activity for Surgery Partners or view top insider-selling stocks.

Which institutional investors are buying Surgery Partners stock?

SGRY stock was purchased by a variety of institutional investors in the last quarter, including Foster Victor Wealth Advisors LLC.
View insider buying and selling activity for Surgery Partners or or view top insider-buying stocks.

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $42.09.

How much money does Surgery Partners make?

Surgery Partners has a market capitalization of $3.76 billion and generates $1.86 billion in revenue each year. The company earns $-116.10 million in net income (profit) each year or ($1.34) on an earnings per share basis.

How many employees does Surgery Partners have?

Surgery Partners employs 10,800 workers across the globe.

What is Surgery Partners' official website?

The official website for Surgery Partners is www.surgerypartners.com.

Where are Surgery Partners' headquarters?

Surgery Partners is headquartered at 310 Seven Springs Way Suite 500, Brentwood TN, 37027.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at (615) 234-5900, via email at [email protected], or via fax at 615-234-5998.